<table border="0" cellpadding="0" cellspacing="0" width="367" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<colgroup>
<col width="44.4444444444445%"></col>
<col width="55.5555555555556%"></col>
</colgroup>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Interacting Drug </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">
<content stylecode="bold">Interaction </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Multivalent cation-containing products including: antacids, sucralfate, multivitamins<br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Decreased moxifloxacin hydrochloride absorption. Take moxifloxacin hydrochloride tabletÂ at least 4 hours before or 8 hours after these products. (<linkhtml href="#Section_2.2">2.2</linkhtml>, <linkhtml href="#Section_7.1">7.1</linkhtml>, <linkhtml href="#Section_12.3">12.3</linkhtml>) <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Warfarin <br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Anticoagulant effect enhanced. Monitor prothrombin time/INR, and bleeding. (<linkhtml href="#Section_6">6</linkhtml>, <linkhtml href="#Section_7.2">7.2</linkhtml>, <linkhtml href="#Section_12.3">12.3</linkhtml>) <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Class IA and Class III antiarrhythmics: <br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Proarrhythmic effect may be enhanced. Avoid concomitant use. (<linkhtml href="#Section_5.6">5.6</linkhtml>, <linkhtml href="#Section_7.5">7.5</linkhtml>) <br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">Antidiabetic agents<br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Carefully monitor blood glucose. (<linkhtml href="#Section_5.11">5.11</linkhtml>, <linkhtml href="#Section_7.3">7.3</linkhtml>)<br/>
</td>
</tr>
</tbody>
</table>